Prediction of small-for-gestational-age neonates: Screening by maternal biochemical markers at 30-34 weeks

Ultrasound in Obstetrics and Gynecology

Volumn 46, Issue 2, 2015, Pages 208-215

  Bakalis, S ^a   Gallo, D M ^a   Mendez, O ^a   Poon, L C ^a   Nicolaides, K H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

free human chorionic gonadotropin; placental growth factor; pre eclampsia; pregnancy associated plasma protein A; pyramid of antenatal care; small for gestational age; soluble fms like tyrosine kinase 1; third trimester screening

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; PLACENTA PROTEIN; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; VASCULOTROPIN RECEPTOR 1;

ADULT; BLOOD; ECHOGRAPHY; FEMALE; FETUS DISEASE; FETUS ECHOGRAPHY; GESTATIONAL AGE; HUMAN; METABOLISM; NEWBORN; PRE-ECLAMPSIA; PREDICTIVE VALUE; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES; PROSPECTIVE STUDY; SMALL FOR DATE INFANT;

ADULT; ALPHA-FETOPROTEINS; BIOMARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; FETAL DISEASES; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, PRENATAL; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84937819242     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.14861     Document Type: Article

References (25)

1. Lindqvist PG, Molin J,. Does antenatal identification of small-for-gestational age fetuses significantly improve their outcome? Ultrasound Obstet Gynecol 2005; 25: 258-264.
2. Bais JMJ, Eskes M, Pel M, Bonsel GJ, Bleker OP,. Effectiveness of detection of intrauterine retardation by abdominal palpation as screening test in a low-risk population: an observational study. Eur J Obstet Gynecol Reprod Biol 2004; 116: 164-169.
3. Lindhard A, Nielsen PV, Mouritsen LA, Zachariassen A, Sørensen HU, Rosenø H,. The implications of introducing the symphyseal-fundal height-measurement. A prospective randomized controlled trial. Br J Obstet Gynaecol 1990; 97: 675-680.
4. Bakalis S, Silva M, Akolekar R, Poon LC, Nicolaides KH,. Prediction of small-for-gestational-age neonates: screening by fetal biometry at 30-34 weeks. Ultrasound Obstet Gynecol 2015; 45: 551-558.
5. Karagiannis G, Akolekar R, Sarquis R, Wright D, Nicolaides KH,. Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11-13 weeks. Fetal Diagn Ther 2011; 29: 148-154.
6. Morris RK, Cnossen JS, Langejans M, Robson SC, Kleijnen J, Ter Riet G, Mol BW, van der Post JA, Khan KS,. Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis. BMC Pregnancy Childbirth 2008; 8: 33.
7. Savvidou MD, Yu CK, Harland LC, Hingorani AD, Nicolaides KH,. Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction. Am J Obstet Gynecol 2006; 195: 1668-1673.
8. Diab AE, El-Behery MM, Ebrahiem MA, Shehata AE,. Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry. Int J Gynaecol Obstet 2008; 102: 146-151.
9. Crispi F, Llurba E, Domínguez C, Martín-Gallán P, Cabero L, Gratacós E,. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2008; 31: 303-309.
10. Espinoza J, Romero R, Nien JK, Gomez R, Kusanovic JP, Gonçalves LF, Medina L, Edwin S, Hassan S, Carstens M, Gonzalez R,. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol 2007; 196: 326.e1-13.
11. Rizos D, Eleftheriades M, Karampas G, Rizou M, Haliassos A, Hassiakos D, Vitoratos N,. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study. European Journal Obstet Gynecol Reprod Biol 2013; 171: 225-230.
12. Herraiz I, Dröge A, Gómez-Montes E, Wolfgang H, Galindo A, Stefan V,. Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction. Obstet Gynecol 2014; 124: 265-273.
13. Robinson HP, Fleming JE,. A critical evaluation of sonar crown-rump length measurements. Br J Obstet Gynaecol 1975; 82: 702-710.
14. Snijders RJ, Nicolaides KH,. Fetal biometry at 14-40 weeks' gestation. Ultrasound Obstet Gynecol 1994; 4: 34-48.
15. Poon LCY, Volpe N, Muto B, Syngelaki A, Nicolaides KH,. Birthweight with gestation and maternal characteristics in live births and stillbirths. Fetal Diagn Ther 2012; 32: 156-165.
16. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM,. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the international society for the study of hypertension in pregnancy (ISSHP). Hypertens Pregnancy 2001; 20: 19-24.
17. Tsiakkas A, Duvdevani N, Wright A, Wright D, Nicolaides KH,. Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol 2015; 45: 591-598.
18. Tsiakkas A, Duvdevani N, Wright A, Wright D, Nicolaides KH,. Serum soluble fms-like tyrosine kinase-1 in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol 2015; 45: 584-590.
19. Wright D, Silva M, Papadopoulos S, Wright A, Nicolaides KH,. Serum pregnancy-associated plasma protein-A in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol 2015; 46: 42-50.
20. Wright D, Papadopoulos S, Silva M, Wright A, Nicolaides KH,. Serum free β-human chorionic gonadotropin in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol 2015; 46: 51-59.
21. Bredaki FE, Sciorio C, Wright A, Wright D, Nicolaides KH,. Serum alpha-fetoprotein in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol 2015; 46: 34-41.
22. Nicolaides KH,. Turning the pyramid of prenatal care. Fetal Diagn Ther 2011; 29: 183-196.
23. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguere Y,. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010; 116: 402-414.
24. Roberge S, Villa P, Nicolaides K, Giguère Y, Vainio M, Bakthi A, Ebrashy A, Bujold E,. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther 2012; 31: 141-146.
25. Yu CK, Papageorghiou AT, Parra M, Palma DR, Nicolaides KH,. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. Ultrasound Obstet Gynecol 2003; 22: 233-239.